Skip to main content

Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

Status: Open to Enrollment
Email us to enroll

Study details

View study details on clinicaltrials.gov.

Locations

  • Fremont
  • Palo Alto
  • Berkeley

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Robert Su, M.D.
Robert Su, M.D.
Principal investigator
View profile

Related clinical trials

View all clinical trials
  • Clinical trial

    Systemic Lupus Erythematosus CYTB323J12201

    A Phase 2, Adaptive, Randomized, Open-label, Assessor-blinded Active-controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Standard of Care in Patients Suffering From Systemic Lupus Erythematosus (SLE) With Active, Refractory Lupus Nephritis (LN)

    Status: Open to Enrollment

  • Clinical trial

    Lower Limb Arterial Occlusion ArtixASCEND 25-001

    The Artix All-in-one Solution for Complete thrombEctomy With eNDovascular Approach

    Status: Open to Enrollment

  • Clinical trial

    Cataract Surgery with Intraocular Lens and Retinal Surgery

    Outcomes of Combined Cataract Surgery With Retinal Surgery for Visually Significant Epiretinal Membrane With Vivity Versus Monofocal Intraocular Lens (Kuo Vivity IOL 2025)

    Status: Open to Enrollment

  • Clinical trial

    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) IMVT-1402-2401

    A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled Study of IMVT-1402 Treatment in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Status: Open to Enrollment

  • Clinical trial

    Inflammatory Bowel Disease BOOM-IBD2

    BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of Inflammatory Bowel Disease (IBD).

    Status: Open to Enrollment

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?